107 related articles for article (PubMed ID: 15262428)
21. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
22. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth.
Zoidl G; Blass-Kampmann S; D'Urso D; Schmalenbach C; Müller HW
EMBO J; 1995 Mar; 14(6):1122-8. PubMed ID: 7720703
[TBL] [Abstract][Full Text] [Related]
23. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters.
Suter U; Snipes GJ; Schoener-Scott R; Welcher AA; Pareek S; Lupski JR; Murphy RA; Shooter EM; Patel PI
J Biol Chem; 1994 Oct; 269(41):25795-808. PubMed ID: 7929285
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional startpoints and methylation patterns in the PMP22 promoters of peripheral nerve, leukocytes and tumor cell lines.
Huehne K; Rautenstrauss B
Int J Mol Med; 2001 Jun; 7(6):669-75. PubMed ID: 11351283
[TBL] [Abstract][Full Text] [Related]
25. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
26. Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells.
Magnaghi V; Veiga S; Ballabio M; Gonzalez LC; Garcia-Segura LM; Melcangi RC
J Peripher Nerv Syst; 2006 Jun; 11(2):111-8. PubMed ID: 16787508
[TBL] [Abstract][Full Text] [Related]
27. Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells.
Makita N; Suzuki M; Asami S; Takahata R; Kohzaki D; Kobayashi S; Hakamazuka T; Hozumi N
Gene; 2008 Apr; 413(1-2):8-17. PubMed ID: 18321663
[TBL] [Abstract][Full Text] [Related]
28. Post-transcriptional regulation of the peripheral myelin protein gene PMP22/gas3.
Bosse F; Brodbeck J; Müller HW
J Neurosci Res; 1999 Jan; 55(2):164-77. PubMed ID: 9972819
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis.
Xu Z; Choudhary S; Voznesensky O; Mehrotra M; Woodard M; Hansen M; Herschman H; Pilbeam C
Cancer Res; 2006 Jul; 66(13):6657-64. PubMed ID: 16818639
[TBL] [Abstract][Full Text] [Related]
30. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
31. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
Haydon RC; Luu HH; He TC
Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
[TBL] [Abstract][Full Text] [Related]
32. Investigation of prevalence and regulation of expression of progression associated protein (PAP).
Gnirke AU; Weidle UH
Anticancer Res; 1998; 18(6A):4363-9. PubMed ID: 9891493
[TBL] [Abstract][Full Text] [Related]
33. Varying survival of motoneurons and activation of distinct molecular mechanism in response to altered peripheral myelin protein 22 gene dosage.
Nattkämper H; Halfter H; Khazaei MR; Lohmann T; Gess B; Eisenacher M; Willscher E; Young P
J Neurochem; 2009 Aug; 110(3):935-46. PubMed ID: 19493167
[TBL] [Abstract][Full Text] [Related]
34. RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.
Wittrant Y; Lamoureux F; Mori K; Riet A; Kamijo A; Heymann D; Redini F
Int J Oncol; 2006 Jan; 28(1):261-9. PubMed ID: 16328004
[TBL] [Abstract][Full Text] [Related]
35. Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions.
Li J; Kleeff J; Esposito I; Kayed H; Felix K; Giese T; Büchler MW; Friess H
J Histochem Cytochem; 2005 Jul; 53(7):885-93. PubMed ID: 15995147
[TBL] [Abstract][Full Text] [Related]
36. Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning.
Olstad OK; Gautvik VT; Reppe S; Rian E; Jemtland R; Ohlsson C; Bruland OS; Gautvik KM
Anticancer Res; 2003; 23(3B):2201-16. PubMed ID: 12894494
[TBL] [Abstract][Full Text] [Related]
37. Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice.
Amici SA; Dunn WA; Notterpek L
J Neurosci Res; 2007 Feb; 85(2):238-49. PubMed ID: 17131416
[TBL] [Abstract][Full Text] [Related]
38. Effect of TNF-alpha on human osteosarcoma cell line Saos2--TNF-alpha regulation of bone sialoprotein gene expression in Saos2 osteoblast-like cells.
Nakayama Y; Kato N; Nakajima Y; Shimizu E; Ogata Y
Cell Biol Int; 2004; 28(10):653-60. PubMed ID: 15516323
[TBL] [Abstract][Full Text] [Related]
39. An 8.5-kb segment of the PMP22 promoter responds to loss of axon signals during Wallerian degeneration, but does not respond to specific axonal signals during nerve regeneration.
Orfali W; Nicholson RN; Guiot MC; Peterson AC; Snipes GJ
J Neurosci Res; 2005 Apr; 80(1):37-46. PubMed ID: 15723356
[TBL] [Abstract][Full Text] [Related]
40. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
